The Global Interdependence Center – Solve Long Covid Initiative Program Series: Medical Research
Date: Thursday, January 6, 2022
Virtual Event
Complimentary video replay is available!
Presentation Document
Event Detail
The Global Interdependence Center – Solve Long Covid Initiative Program Series: Medical Research
The Global Interdependence Center, in partnership with the Solve Long Covid Initiative, is delighted to announce a year-long webinar and conference series exploring the pandemic’s long-term healthcare, policy, and economic impact, specifically the implications of long haul COVID or long COVID.
This program, in partnership with the Solve Long Covid Initiative, will focus on medical research: what we know so far and how long COVID can reshape the field of medical research in the future. Join Amy Proal, Ph.D., Microbiologist/Research Team Coordinator for the PolyBio Research Foundation, for a presentation and audience Q&A with Emily Taylor, Vice President of Advocacy and Community Engagement at Solve M.E. Plus remarks from Oved Amitay, the Chief Executive Officer at Solve M.E., and William Kennedy, GIC Vice Chair of Programs and Co-Founder, CEO and CIO of RiskBridge Advisors.
Over the next twelve months, GIC and SLCI will bring together world-class immunologists, medical experts, policymakers, and economists to explore critical insights into defining, diagnosing, optimizing treatments, and healthcare policies for long COVID and analyzing its impact on U.S. and global labor markets.
Click here for the video replay.
About the David R. Kotok Global Healthcare Series
GIC launched the David R. Kotok Global Healthcare Series in 2020; a virtual program series focused on the roles health and healthcare policy play in the interdependent global community. As a part of the series, the GIC has launched the “Analyzing Pandemics: Economic and Policy Impacts” executive briefings to explore the 100-year global pandemic event. Past briefings focused on the disease and the cure, COVID-19’s impact on food supply chains, artificial intelligence, climate change, and higher education.
In 2021, David Kotok and the Solve Long COVID Initiative offered a new gift to the GIC for funding, sponsorship, and logistical support for the Long COVID Program Series. The series serves as a neutral forum to elevate, vet, and share information about changing interdependencies caused by Long COVID’s impact on medical research, health care policy, fiscal policy, monetary policy, finance, trade, politics, and culture.
About the Solve Long Covid Initiative
Based on more than 30 years of research and advocacy experience advancing the understanding of post-infection diseases, Solve M.E. was one of the first organizations to recognize the emerging threat of the long-term debilitating outcomes of the global COVID-19 pandemic. As early as April 2020, Solve M.E. called on Congress to have immediate response measures, recommending budget appropriation to the National Institutes of Health (NIH) for post-viral research. This was the early, first step in the Solve Long Covid Initiative.
Event Location
Speakers
Oved Amitay
Chief Executive Officer at Solve M.E.Oved Amitay is the Chief Executive Officer at Solve M.E. He has dedicated most of his professional career to the development of life-changing therapeutic options for people affected by rare genetic diseases.
William Kennedy
GIC Board Chair and CEO, RiskBridge Advisors, LLCWilliam Kennedy is the co-founder, CEO, and Chief Investment Officer of RiskBridge Advisors, an independent, full-service investment office serving insurers, endowments and foundations, and individual investors. He is responsible for RiskBridge’s business and investment activities and has over 30 years of capital market research and investment experience.
Amy Proal, Ph.D.
Microbiologist/Research Team Coordinator, PolyBio Research FoundationDr. Proal is a microbiologist who studies the molecular mechanisms by which bacterial, fungal and viral pathogens dysregulate human gene expression, immunity and metabolism. Her work further examines how dysbiosis of the human microbiome and/or the human virome can contribute to chronic inflammatory disease processes.
Emily Taylor
Vice President of Advocacy and Engagement, Solve M.E.Emily Taylor is the Director of Advocacy and Engagement for Solve M.E. She brings to the organization over fifteen years of policy, organization, and advocacy experience in both the non-profit and government sectors.
Partners
